Brochure
18 Oct 2024
Abzena Capabilities Overview
PDF 795 kB
Access our corporate brochure to learn why we are considered to be the leading bioconjugate, antibody-drug conjugate (ADC), and complex biologics CDMO + CRO.
Content provided by our supplier
Abzena
-
US -
2018On CPHI since
-
3Certificates
-
500 - 999Employees
Company types
Primary activities
Other Content from Abzena (1)
-
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance